Even though several Id-dependent targets have been identified, we still lack a comprehensive picture of the downstream molecular mechanisms controlled by Id and their associated pathways mediating breast cancer progression and metastasis particularly in the poor prognostic TNBC subtype. Here, ID1 is linked to breast cancer.